Literature DB >> 28100880

Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction.

Tomoaki Natsukawa1,2, Norikazu Maeda1,3, Shiro Fukuda1, Masaya Yamaoka1, Yuya Fujishima1, Hirofumi Nagao1, Fumi Sato1, Hitoshi Nishizawa1, Hirotaka Sawano2, Yasuyuki Hayashi2, Tohru Funahashi1,3, Tatsuro Kai2, Iichiro Shimomura1.   

Abstract

AIMS: Adiponectin, an adipocyte-specific secretory protein, abundantly exists in the blood stream while its concentration paradoxically decreases in obesity. Hypoadiponectinemia is one of risks of cardiovascular diseases. However, impact of serum adiponectin concentration on acute ischemic myocardial damages has not been fully clarified. The present study investigated the association of serum adiponectin and creatine kinase (CK)-MB levels in subjects with ST-segment elevation myocardial infarction (STEMI).
METHODS: This study is a physician-initiated observational study and is also registered with the University Hospital Medical Information Network (Number: UMIN 000014418). Patients were admitted to Senri Critical Care Medical Center, given a diagnosis of STEMI, and treated by primary percutaneous coronary intervention (PCI). Finally, 49 patients were enrolled and the association of serum adiponectin, CK-MB, and clinical features were mainly analyzed.
RESULTS: Serum adiponectin levels decreased rapidly and reached the bottom at 24 hours after recanalization. Such reduction of serum adiponectin was inversely correlated with the area under the curve (AUC) of serum CK-MB (p=0.013). Serum adiponectin concentrations were inversely correlated with AUC of serum CK-MB. In multivariate analysis, serum adiponectin concentration on admission (p=0.002) and collateral (p=0.037) were significantly and independently correlated with serum AUC of CK-MB.
CONCLUSION: Serum AUC of CK-MB in STEMI subjects was significantly associated with serum adiponectin concentration on admission and reduction of serum adiponectin levels from baseline to bottom. The present study may provide a possibility that serum adiponectin levels at acute phase are useful in the prediction for prognosis after PCI-treated STEMI subjects.

Entities:  

Keywords:  Acute coronary syndrome; Adiponectin; CK-MB; Infarct size; Myocardial infarction

Mesh:

Substances:

Year:  2017        PMID: 28100880      PMCID: PMC5556187          DOI: 10.5551/jat.38232

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  50 in total

1.  CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population.

Authors:  Hiroko Morisaki; Itaru Yamanaka; Naoharu Iwai; Yoshihiro Miyamoto; Yoshihiro Kokubo; Tomonori Okamura; Akira Okayama; Takayuki Morisaki
Journal:  Hum Mutat       Date:  2011-12-08       Impact factor: 4.878

Review 2.  Infarct size reduction in acute myocardial infarction.

Authors:  E McAlindon; C Bucciarelli-Ducci; M S Suleiman; A Baumbach
Journal:  Heart       Date:  2014-05-14       Impact factor: 5.994

3.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

4.  CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass.

Authors:  Aya Kitamoto; Takuya Kitamoto; Takahiro Nakamura; Tomoaki Matsuo; Yoshio Nakata; Hideyuki Hyogo; Hidenori Ochi; Seika Kamohara; Nobuyuki Miyatake; Kazuaki Kotani; Ikuo Mineo; Jun Wada; Yuji Ogawa; Masato Yoneda; Atsushi Nakajima; Tohru Funahashi; Shigeru Miyazaki; Katsuto Tokunaga; Hiroaki Masuzaki; Takato Ueno; Kazuaki Chayama; Kazuyuki Hamaguchi; Kentaro Yamada; Toshiaki Hanafusa; Shinichi Oikawa; Toshiie Sakata; Kiyoji Tanaka; Yuji Matsuzawa; Kikuko Hotta
Journal:  J Atheroscler Thromb       Date:  2015-10-01       Impact factor: 4.928

5.  Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation.

Authors:  A Kurata; H Nishizawa; S Kihara; N Maeda; M Sonoda; T Okada; K Ohashi; T Hibuse; K Fujita; A Yasui; A Hiuge; M Kumada; H Kuriyama; I Shimomura; T Funahashi
Journal:  Kidney Int       Date:  2006-09-20       Impact factor: 10.612

6.  Impact of a single intracoronary administration of adiponectin on myocardial ischemia/reperfusion injury in a pig model.

Authors:  Kazuhisa Kondo; Rei Shibata; Kazumasa Unno; Masayuki Shimano; Masakazu Ishii; Tetsutaro Kito; Satoshi Shintani; Kenneth Walsh; Noriyuki Ouchi; Toyoaki Murohara
Journal:  Circ Cardiovasc Interv       Date:  2010-03-23       Impact factor: 6.546

7.  Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice.

Authors:  Keisuke Matsuda; Yuya Fujishima; Norikazu Maeda; Takuya Mori; Ayumu Hirata; Ryohei Sekimoto; Yu Tsushima; Shigeki Masuda; Masaya Yamaoka; Kana Inoue; Hitoshi Nishizawa; Shunbun Kita; Barbara Ranscht; Tohru Funahashi; Iichiro Shimomura
Journal:  Endocrinology       Date:  2014-12-16       Impact factor: 4.736

Review 8.  Cardiovascular-metabolic impact of adiponectin and aquaporin.

Authors:  Norikazu Maeda; Tohru Funahashi; Iichiro Shimomura
Journal:  Endocr J       Date:  2013-01-29       Impact factor: 2.349

9.  Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.

Authors:  Masafumi Kitakaze; Masanori Asakura; Jiyoong Kim; Yasunori Shintani; Hiroshi Asanuma; Toshimitsu Hamasaki; Osamu Seguchi; Masafumi Myoishi; Tetsuo Minamino; Takahiro Ohara; Yoshiyuki Nagai; Shinsuke Nanto; Kouki Watanabe; Shigeru Fukuzawa; Atsushi Hirayama; Natsuki Nakamura; Kazuo Kimura; Kenshi Fujii; Masaharu Ishihara; Yoshihiko Saito; Hitonobu Tomoike; Soichiro Kitamura
Journal:  Lancet       Date:  2007-10-27       Impact factor: 79.321

10.  Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.

Authors:  Amir Halkin; Gregg W Stone; Cindy L Grines; David A Cox; Barry D Rutherford; Paolo Esente; Carol M Meils; Per Albertsson; Anthony Farah; James E Tcheng; Alexandra J Lansky; Roxana Mehran
Journal:  J Am Coll Cardiol       Date:  2006-02-10       Impact factor: 24.094

View more
  7 in total

1.  Adiponectin and T-Cadherin: a Tree for Biomarkers in ST-Elevation or Non-ST-Elevation Myocardial Infarction.

Authors:  Michio Shimabukuro
Journal:  J Atheroscler Thromb       Date:  2017-05-15       Impact factor: 4.928

2.  Increased serum adiponectin predicts improved coronary flow and clinical outcomes in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Authors:  Siwen Liang; Hongwei Li; Xuhua Shen; Ruifeng Liu
Journal:  J Clin Lab Anal       Date:  2019-02-19       Impact factor: 2.352

3.  High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

Authors:  Yu Du; Yingxin Zhao; Yong Zhu; Chenping Hu; Jianwei Zhang; Qingwei Ji; Wei Liu; Hongya Han; Lixia Yang; Dai Zhang; Shan Tong; Zhijian Wang; Yonghe Guo; Xiaoli Liu; Yujie Zhou
Journal:  J Atheroscler Thromb       Date:  2019-02-15       Impact factor: 4.928

4.  Time-Dependent Change in Omentin-1 Level Correlated with Early Improvement of Myocardial Function in Patients with First Anterior ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention.

Authors:  Yong Zhu; Chengping Hu; Yu Du; Jianwei Zhang; Jinxing Liu; Guojie Cheng; Hongya Han; Yingxin Zhao
Journal:  J Atheroscler Thromb       Date:  2019-03-09       Impact factor: 4.928

5.  Diagnostic value and prognostic significance of CTRP9 combined with pentraxin-3 in acute coronary syndrome.

Authors:  Na Jiang; Shulong Zhou; Guanglei Wang; Ningning Jiang; Huaixin Wang; Feng Zhao
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

6.  Efficacy of Buqi Huoxue Decoction Combined with Cardiac Rehabilitation Nursing after Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction and Its Influence on Prognosis.

Authors:  Haiping Du; Hui Fu; Jing Yu; Zuowang Cheng; Yanhong Zhang
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

7.  An Aptamer-based Biosensor for Troponin I Detection in Diagnosis of Myocardial Infarction.

Authors:  M Negahdary; M Behjati-Ardakani; N Sattarahmady; H Heli
Journal:  J Biomed Phys Eng       Date:  2018-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.